Mark E. Prince

50.5k total citations · 2 hit papers
232 papers, 9.9k citations indexed

About

Mark E. Prince is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Mark E. Prince has authored 232 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Otorhinolaryngology, 94 papers in Oncology and 89 papers in Surgery. Recurrent topics in Mark E. Prince's work include Head and Neck Cancer Studies (104 papers), Head and Neck Surgical Oncology (31 papers) and Cancer Cells and Metastasis (27 papers). Mark E. Prince is often cited by papers focused on Head and Neck Cancer Studies (104 papers), Head and Neck Surgical Oncology (31 papers) and Cancer Cells and Metastasis (27 papers). Mark E. Prince collaborates with scholars based in United States, Canada and United Kingdom. Mark E. Prince's co-authors include Gregory T. Wolf, Carol R. Bradford, Thomas E. Carey, Laurie Ailles, Douglas B. Chepeha, Avraham Eisbruch, Michael J. Kaplan, Irving L. Weissman, Francis P. Worden and Michael F. Clarke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.

In The Last Decade

Mark E. Prince

222 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

2007 1.7k citations Mark E. Prince, Gregory T. Wolf et al. profile →
EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer

2008 493 citations Julia S. Lee, Francis P. Worden et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. Prince United States	48	4.7k	3.5k	3.0k	2.7k	1.9k	232	9.9k
Athanassios Argiris United States	47	4.2k 0.9×	3.5k 1.0×	2.7k 0.9×	2.2k 0.8×	923 0.5×	243	8.9k
David Raben United States	48	6.8k 1.4×	5.2k 1.5×	4.4k 1.5×	3.7k 1.4×	1.8k 0.9×	236	15.2k
Francis P. Worden United States	49	3.5k 0.7×	3.5k 1.0×	1.7k 0.6×	3.1k 1.1×	1.4k 0.7×	257	9.1k
Mark A. Varvares United States	42	2.6k 0.6×	2.0k 0.6×	1.7k 0.6×	2.1k 0.8×	1.0k 0.5×	231	7.2k
Erich M. Sturgis United States	56	4.0k 0.8×	4.9k 1.4×	3.1k 1.0×	3.2k 1.2×	1.7k 0.9×	305	11.1k
Bhuvanesh Singh United States	59	5.7k 1.2×	1.8k 0.5×	4.8k 1.6×	3.2k 1.2×	1.8k 1.0×	169	13.6k
James A. Bonner United States	53	6.6k 1.4×	4.8k 1.4×	3.0k 1.0×	3.1k 1.2×	983 0.5×	232	14.0k
Richard J. Wong United States	57	3.6k 0.8×	3.3k 0.9×	1.7k 0.6×	3.8k 1.4×	662 0.3×	293	10.3k
J. Giralt Spain	29	5.3k 1.1×	5.7k 1.6×	2.2k 0.7×	4.3k 1.6×	974 0.5×	118	11.7k
K. Kian Ang United States	43	3.1k 0.6×	4.9k 1.4×	2.0k 0.7×	3.3k 1.2×	1.1k 0.6×	75	9.0k

Countries citing papers authored by Mark E. Prince

Since Specialization

Citations

This map shows the geographic impact of Mark E. Prince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Prince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Prince more than expected).

Fields of papers citing papers by Mark E. Prince

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Prince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Prince. The network helps show where Mark E. Prince may publish in the future.

Co-authorship network of co-authors of Mark E. Prince

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Prince. A scholar is included among the top collaborators of Mark E. Prince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Prince. Mark E. Prince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prince, Mark E., et al.. (2025). 2D metal-organic framework Cu3(HHTP)2 composite electrode for flexible energy storage applications. Journal of Power Sources. 631. 236214–236214. 4 indexed citations

Benjamin, William J., Allen L. Feng, Molly E. Heft Neal, et al.. (2024). Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer. Oral Oncology. 156. 106917–106917.

Neal, Molly E. Heft, Catherine T. Haring, Emily L. Bellile, et al.. (2024). Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage Laryngectomy. Clinical Cancer Research. 30(14). 2910–2916. 3 indexed citations

Dalal, Prarthana, Sarah M. Dermody, Collin Brummel, et al.. (2024). Clinical outcomes in salivary adenoid cystic carcinoma.. Journal of Clinical Oncology. 42(16_suppl). 6102–6102.

Haring, Catherine T., Sarah M. Dermody, Collin Brummel, et al.. (2023). Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols. Cancer. 129(18). 2817–2827. 32 indexed citations

Chen, Michelle, Sarah M. Dermody, Andrew J. Rosko, et al.. (2021). A Consideration for Surgical Management in Select T4b Oral Cavity Squamous Cell Carcinoma. Annals of Otology Rhinology & Laryngology. 131(6). 609–616. 3 indexed citations

Gottschlich, Anna, Kristin Bevilacqua, Andrés M. Pineda, et al.. (2019). HPV self-sampling acceptability in rural and indigenous communities in Guatemala: a cross-sectional study. BMJ Open. 9(10). e029158–e029158. 34 indexed citations

Marchiano, Emily, Andrew C. Birkeland, Kevin J. Kovatch, et al.. (2018). Defining the Young Oral Cavity Cancer Patient. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1354–1355. 1 indexed citations

Prince, Mark E. & Tim Wenham. (2018). Heparin-induced thrombocytopaenia. Postgraduate Medical Journal. 94(1114). 453–457. 22 indexed citations

10.

Edwards, Bruce, et al.. (2017). Otolaryngology outreach to Komfo Anokye Teaching Hospital: a medical and educational partnership. The Journal of Laryngology & Otology. 131(7). 608–613. 5 indexed citations

11.

Walline, Heather M., Christine M. Komarck, Jonathan B. McHugh, et al.. (2016). Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma. Molecular Cancer Research. 14(10). 941–952. 41 indexed citations

12.

Zhang, Yanxiao, Lada A. Koneva, Shama Virani, et al.. (2016). Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures. Clinical Cancer Research. 22(18). 4735–4745. 110 indexed citations

13.

Lee, Jae, Krithika Suresh, Eli Sapir, et al.. (2016). Predictors of severe long-term toxicity after re-irradiation for head and neck cancer. Oral Oncology. 60. 32–40. 28 indexed citations

14.

Coupland, Douglas, et al.. (2014). Douglas Coupland : Everywhere is Anywhere is Anything is Everything.

15.

Ning, Ning, Qin Pan, Fang Zheng, et al.. (2012). Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity. Cancer Research. 72(7). 1853–1864. 177 indexed citations

16.

Chinn, Steven B., et al.. (2012). The role of head and neck squamous cell carcinoma cancer stem cells in tumorigenesis, metastasis, and treatment failure. Frontiers in Endocrinology. 3. 90–90. 40 indexed citations

17.

Feng, Felix Y., Hyungjin Myra Kim, Teresa Lyden, et al.. (2010). Intensity-Modulated Chemoradiotherapy Aiming to Reduce Dysphagia in Patients With Oropharyngeal Cancer: Clinical and Functional Results. Journal of Clinical Oncology. 28(16). 2732–2738. 261 indexed citations

18.

Dong, Zhihong, Atsushi Imai, Joseph I. Helman, et al.. (2010). Endothelial Cell-Initiated Signaling Promotes the Survival and Self-Renewal of Cancer Stem Cells. Cancer Research. 70(23). 9969–9978. 201 indexed citations

19.

Divi, Vasu, Francis P. Worden, Mark E. Prince, et al.. (2009). Chemotherapy alone for organ preservation in advanced laryngeal cancer. Head & Neck. 32(8). 1040–1047. 14 indexed citations

20.

Lansford, Christopher D., Mary Jo Kocan, Richard Marggraf Turley, et al.. (2008). Improved Outcomes in Patients With Head and Neck Cancer Using a Standardized Care Protocol for Postoperative Alcohol Withdrawal. Archives of Otolaryngology - Head and Neck Surgery. 134(8). 865–865. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact